Afuco™ Anti-Human CLDN1 ADCC Therapeutic Antibody, ADCC Enhanced
Anti-CLDN1 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. Monoclonal antibodies against the HCV entry factor CLDN1 might be used to prevent HCV infection, such as after liver transplantation, and might also restrain virus spread in chronically infected patients.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-157CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | CLDN1 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles. |